Matthew F. Kohler

TitleDirector, Division of Gynecologic Oncology
InstitutionMedical University of South Carolina
DepartmentGynecologic Oncology
AddressP.O. Box MSC 619
634
96 Jonathan Lucas St.
Phone843-792-4500
Fax843-792-0533
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Buchanan T, Pierce JY, Graybill W, Kohler M, Creasman W. Why do we continue to overtreat stage Ia carcinoma of the cervix? Am J Obstet Gynecol. 2017 10; 217(4):413-417. PMID: 28522321.
      Citations:    
    2. Neal SA, Graybill WS, Garrett-Mayer E, McDowell ML, McLean VE, Watson CH, Pierce JY, Kohler MF, Creasman WT. Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? Gynecol Oncol. 2016 08; 142(2):278-82. PMID: 27261326.
      Citations:    
    3. Rimawi BH, Graybill W, Pierce JY, Kohler M, Eriksson EA, Shary MT, Crookes B, Soper DE. Necrotizing Fasciitis and Toxic Shock Syndrome from Clostridium septicum following a Term Cesarean Delivery. Case Rep Obstet Gynecol. 2014; 2014:724302. PMID: 24822140.
      Citations:    
    4. Billingsley CC, Kohler MF, Creasman WT, Madory JE, Young JL. A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis. 2012 Apr; 16(2):145-8. PMID: 22227838.
      Citations:    
    5. Opfermann KJ, Wahlquist A, Watkins J, Kohler M, Jenrette J. Impact of point A asymmetry on local control and survival for low dose-rate (LDR) brachytherapy in cervical cancer. J Contemp Brachytherapy. 2012 Mar; 4(1):3-7. PMID: 23346133.
      Citations:    
    6. Alvarez Secord A, Berchuck A, Higgins RV, Nycum LR, Kohler MF, Puls LE, Holloway RW, Lewandowski GS, Valea FA, Havrilesky LJ. A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Cancer. 2012 Jul 01; 118(13):3283-93. PMID: 22072307.
      Citations:    
    7. Pokrzywinski R, Secord AA, Havrilesky LJ, Puls LE, Holloway RW, Lewandowski GS, Higgins RV, Nycum LR, Kohler MF, Revicki DA. Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial. Gynecol Oncol. 2011 Dec; 123(3):505-10. PMID: 21945310.
      Citations:    
    8. Havrilesky LJ, Pokrzywinski R, Revicki D, Higgins RV, Nycum LR, Kohler MF, Berchuck A, Myers ER, Secord AA. Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer. Cancer. 2012 Jan 15; 118(2):386-91. PMID: 21598242.
      Citations:    
    9. Watkins JM, Kearney PL, Opfermann KJ, Ackerman SJ, Jenrette JM, Kohler MF. Ultrasound-guided tandem placement for low-dose-rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation. Ultrasound Obstet Gynecol. 2011 Feb; 37(2):241-4. PMID: 20922705.
      Citations:    
    10. Creasman WT, Kohler M, Korte JE. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3. PMID: 19539891.
      Citations:    
    11. Batchelor EC, Watkins JM, Creasman WT, Kohler MF, Sinha D, Jenrette JM. The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8. PMID: 18774213.
      Citations:    
    12. Sapp H, Goetzl L, Creasman W, Kohler M, Underwood P, Esnaola N. Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7. PMID: 18565488.
      Citations:    
    13. Kohler MF, Creasman WT. Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium. Future Oncol. 2008 Jun; 4(3):379-87. PMID: 18518763.
      Citations:    
    14. Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M, Creasman WT. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83. PMID: 15982726.
      Citations:    
    15. Mathur SP, Mathur RS, Creasman WT, Underwood PB, Kohler M. Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing. Cancer Biomark. 2005; 1(2-3):183-91. PMID: 17192039.
      Citations:    
    16. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004 Dec; 95(3):593-6. PMID: 15581969.
      Citations:    
    17. Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol. 2004 Feb; 92(2):525-9. PMID: 14766243.
      Citations:    
    18. Mathur SP, Mathur RS, Underwood PB, Kohler MF, Creasman WT. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93. PMID: 14675666.
      Citations:    
    Kohler's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (83)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _